Clinical Trial Update: A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD [Phase 2]

View source ↗

Summary

This document notes a Phase IIa randomized, double-blind, placebo-controlled trial of JKN2403 for chronic obstructive pulmonary disease, which is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• JKN2403

Snippet

Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd | Conditions: COPD (Chronic Obstructive Pulmonary Disease) | Phase 2 | Status: RECRUITING